Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Katia Vandenbulcke

Publications & Research Data

Awards & Distinctions

4 Results

2006

In vitro studie van ²¹³Bi-rituximab voor behandeling van B-cel chronisch lymfatische leukemie

K VandenbulckeG Slegers

2004

The use of EBV-transformed cell lines of breast cancer patients to measure chromosomal radiosensitivity

Ans BaeyensHubert ThierensKatia VandenbulckeLeo De RidderAnne Vral

A1 Journal Article in MUTAGENESIS

The use of IL-2 cultures to measure chromosomal radiosensitivity in breast cancer patients

Ans BaeyensKatia VandenbulckeJan PhilippéHubert ThierensLeo De RidderAnne Vral

A1 Journal Article in MUTAGENESIS

2003

In vitro evaluation of Bi-213-rituximab versus external gamma irradiation for the treatment of B-CLL patients: relative biological efficacy with respect to apoptosis induction and chromosomal damage

Katia VandenbulckeFILIP DE VOSFritz OffnerJan PhilippéC APOSTOLIDISR MOLINETTK NIKULAKlaus BacherV DE GELDERAnne Vral et al.

A1 Journal Article in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING